Díaz Villamarín, Xando Author
Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation
- Díaz-Villamarín X.
- Fernández-Varón E.
- Rojas Romero M.C.
- Callejas-Rubio J.L.
- Cabeza-Barrera J.
- Rodríguez-Nogales A.
- Gálvez J.
- Morón R.
Biomedicine & Pharmacotherapy - 1/12/2023
- CiteScore: 12.6 (2022)
- Scopus
- ORCID
Pharmacogenetics of siponimod: A systematic review
- Díaz-Villamarín X.
- Piñar-Morales R.
- Barrero-Hernández F.J.
- Antúnez-Rodríguez A.
- Cabeza-Barrera J.
- Morón-Romero R.
Biomedicine & Pharmacotherapy - 1/09/2022
- CiteScore: 12.6 (2022)
- SJR: 1.366 (2022
- SNIP: 1.576 (2022
- Scopus
- ORCID
Pharmacogenetic polymorphisms affecting bisoprolol response
- Castaño-Amores C.
- Díaz-Villamarín X.
- Pérez-Gutiérrez A.M.
- Antúnez-Rodríguez A.
- Pozo-Agundo A.
- Moreno-Escobar E.
- Sánchez-Ramos J.G.
- Martínez-González L.J.
- Dávila-Fajardo C.L.
Biomedicine & Pharmacotherapy - 1/10/2021
- CiteScore: 12.6 (2022)
- SJR: 1.194 (2021
- SNIP: 1.502 (2021
- Scopus
- ORCID
The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention with stent.
Data in brief - 20/12/2016
- ORCID
Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine
- Dávila-Fajardo C.L.
- Díaz-Villamarín X.
- Antúnez-Rodríguez A.
- Fernández-Gómez A.E.
- García-Navas P.
- Martínez-González L.J.
- Dávila-Fajardo J.A.
- Barrera J.C.
Genes - 1/04/2019
- Scopus
- ORCID
Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis
- Díaz-Villamarín X.
- Blánquez-Martínez D.
- Pozo-Agundo A.
- Pérez-Gutiérrez A.M.
- Muñoz-ávila J.I.
- Antúnez-Rodríguez A.
- Fernández-Gómez A.E.
- García-Navas P.
- Martínez-González L.J.
- Dávila-Fajardo C.L.
Genes - 1/11/2020
- Scopus
- ORCID
Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
- Koufaki M.I.
- Fragoulakis V.
- Díaz-Villamarín X.
- Karamperis K.
- Vozikis A.
- Swen J.J.
- Dávila-Fajardo C.L.
- Vasileiou K.Z.
- Patrinos G.P.
- Mitropoulou C.
Human Genomics - 7/06/2023
- CiteScore: 8.8 (2022)
- Scopus
- ORCID
Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent.
- Sánchez-Ramos J.
- Dávila-Fajardo C.L.
- Toledo Frías P.
- Díaz Villamarín X.
- Martínez-González L.J.
- Martínez Huertas S.
- Burillo Gómez F.
- Caballero Borrego J.
- Bautista Pavés A.
- Marín Guzmán M.C.
- Ramirez Hernández J.A.
- Correa Vilches C.
- Cabeza Barrera J.
International journal of cardiology - 26/09/2016
- CiteScore: 7 (2022)
- SJR: 1.603 (2016
- SNIP: 0.896 (2016
- Scopus
- ORCID
Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients
- Blánquez-Martínez D.
- Díaz-Villamarín X.
- Antúnez-Rodríguez A.
- Pozo-Agundo A.
- Muñoz-ávila J.I.
- Martínez-González L.J.
- Dávila-Fajardo C.L.
Pharmaceutics - 1/11/2021
- Scopus
- ORCID
Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients
- Blánquez-Martínez D.
- Díaz-Villamarín X.
- García-Rodríguez S.
- Antúnez-Rodríguez A.
- Pozo-Agundo A.
- Martínez-González L.J.
- Muñoz-ávila J.I.
- Dávila-Fajardo C.L.
Pharmaceutics - 26/07/2022
- Scopus
- ORCID
This author has no books, chapters or theses.
This author has no conferences.
This author has no patents.
This author has no reports or other types of publications.
h index
Scopus: 8
i10 index
Scopus: 8
Web of Science: 0
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
- This author has no currently assigned projects.